首页> 外文期刊>Gastroenterology Report >New-onset of celiac disease during interferon-based therapy for hepatitis C
【24h】

New-onset of celiac disease during interferon-based therapy for hepatitis C

机译:基于干扰素的丙型肝炎治疗期间新出现的腹腔疾病

获取原文
           

摘要

We present the case of a patient who first developed symptoms of celiac disease while on interferon-based therapy for treatment of chronic hepatitis C. He required hospital admission for symptom management and diagnostic work-up of severe diarrhoea. He made a rapid recovery with a gluten-free diet and was able to continue therapy. Consideration should be given to screening for celiac disease prior to the commencement of interferon-based therapy, particularly in high-prevalence populations.
机译:我们介绍了一名患者,该患者在进行基于干扰素的慢性丙型肝炎治疗时首先出现了腹腔疾病的症状。他需要住院以进行症状处理和严重腹泻的诊断检查。他以无麸质饮食迅速康复,并能够继续治疗。在开始基于干扰素的治疗之前,尤其是在高流行人群中,应考虑筛查乳糜泻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号